The 20 Best WT1-Related Wilms Tumor Syndromes Doctors Near Me in New Hyde Park, NY

Louis Kavoussi, MD, MBA, Director of teleintervention at Northwell. He is a world-renowned urologic surgeon who brings more than 30 years of specialized expertise in minimally invasive urological surgery. His area of focus includes treating a wide range of urologic diseases, including kidney obstructions, renal stones and urologic cancer. At the forefront of innovation, Dr. Kavoussi pioneered several new surgical techniques, including the first minimally invasive approaches to kidney surgery for kidney cancer and kidney donation. He was also part of the team that performed the first laparoscopic prostate removal for cancer. In 1999, Dr. Kavoussi received a Smithsonian Computerworld Permanent Collection award for his work in developing telerounding, the starting point of telehealth medicine-to facilitate physician communication with hospitalized patients. Before joining Northwell in 2005 as chair of urology, Dr. Kavoussi completed his medical degree at the State University of New York at Buffalo. He obtained his urologic training at Washington University of St. Louis and, directly following residency, was named chief of urology at the Jewish Hospital of St. Louis. In 1991, he was appointed assistant professor at Harvard School of Medicine and director of endourology at the Brigham and Women's Hospital. In 1993, he joined the faculty of Johns Hopkins University School of Medicine, where he was vice chairman of urology and named a Patrick C. Walsh Distinguished Professor. Dr. Kavoussi values a team approach to care, and often collaborates with other specialists to create personalized and comprehensive treatment plans. His patients appreciate his easygoing personality and thoughtfulness. As the Waldbaum-Gardner Distinguished Professor of Urology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Dr. Kavoussi is passionate about training the next generation of surgeons. He has presented his work and given live surgical demonstrations at conferences around the world and has more than 500 academic publications. Dr. Kavoussi is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Reconstructive Urology Surgery. Dr. Kavoussi is board certified in American Board Of Urology.

Joph Steckel is a Urologist practicing medicine in Lake Success, New York. Dr. Steckel is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, Nephrectomy, and Reconstructive Urology Surgery. Dr. Steckel is board certified in American Board Of Urology.

"Xinhua Zhu, MD, PhD, is a medical oncologist and hematologist at Monter Cancer Center, where he specializes in treating genitourinary cancer, including cancer of the prostate, kidney, bladder and testicles. He focuses on compassionate, evidence-based care, rooted in his research background.""My research helps me think outside the box when creating treatment plans,"" says Dr. Zhu, ""and enables me to explain to patients the mechanisms behind the treatments I'm using."" His research interests include finding new treatment targets for generating hormone resistance in prostate cancer and metastatic castration-resistant prostate cancer, exploring biomarkers in bladder cancer to guide decisions about chemotherapy, exploring the mechanisms for kidney cancer metastasis, and investigating the effectiveness of immunotherapy for genitourinary cancers.Dr. Zhu earned his medical degree at Suzhou Medical College and practiced internal medicine in China. He obtained his PhD in cancer study at Shanghai Jiao Tong University School of Medicine, then moved to the United States for postdoctoral research training at Memorial Sloan Kettering Cancer Center, an internal medicine residency at Mount Sinai School of Medicine. He attended NYU School of Medicine for fellowship training in hematology and medical oncology.In 2013, he joined Northwell Health, where he regularly meets with a multidisciplinary group of pathologists, radiologists, radiation oncologists, surgical oncologists, geneticists and the Molecular Tumor Board to create treatment plans.As an associate professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, he twice received the Medical Oncology/Hematology Fellowship Program Teacher of the Year Award. Dr. Zhu is also a phase 1 cancer research program director at Monter Cancer Center. He is assistant investigator at the Feinstein Institutes for Medical Research, and a member of the American Society of Clinical Oncology, the American Association of Cancer Research, and the Principal Investigator for the Northwell Health NCI Community Oncology Research Program (NCORP)For Dr. Zhu, being able to pursue both scientific investigation and patient care is the best part of his work. ""I can take research from the bench to the bedside, providing people with the best possible treatments,"" he says.". Dr. Zhu is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, Prostate Cancer, and Clear Cell Sarcoma. Dr. Zhu is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Kai Tsao, MD, MS, is the system chief of solid tumor oncology, medical director of the R.J. Zuckerberg Cancer Center, and medical director of the medical oncology prostate cancer program at the Northwell Cancer Institute. He specializes in cancers of the genitourinary organs and has more than a decade of clinical experience. His research focuses on the development of biomarkers and novel therapies for patients with genitourinary cancers.Dr. Tsao was inspired to become an oncologist after witnessing many close family and friends suffering from cancer. He completed medical school training at SUNY Downstate, an internal medicine residency at Long Island Jewish Medical Center, and a fellowship in hematology and medical oncology at Mount Sinai Hospital. He earned a master's degree in healthcare delivery leadership at Icahn School of Medicine at Mount Sinai and completed Lean Six Sigma training at Johns Hopkins.Prior to joining Northwell, Dr. Tsao served as medical director of the Ruttenberg Treatment Center, medical director of the medical oncology prostate cancer program, and physician leader for internal oncology collaborations at the Mount Sinai Hospital, Tisch Cancer Institute. In these roles, Dr. Tsao and his team built a cancer center that is patient centered, quality driven, scientifically innovative, and provided multi-disciplinary care to patients with cancer.For me, patient care much more than the cancer diagnosis and treatment. It is essential to address the many needs of our cancer patients: emotional well-being, social support, nutrition, physical activity, financial challenges and more. We aim to provide the best support for our patients, one at a time.Dr. Tsao is an accomplished physician-scientist who has authored more than 80 peer-reviewed publications in the field of genitourinary oncology. He serves as associate editor of Genitourinary Oncology, Frontiers in Oncology. His leadership in carrying out complex clinical trials in targeted therapies and immunotherapies positions his patients at the forefront of cutting-edge cancer research and patient-centered care.What I most enjoy every day is seeing patients under our care, despite the devastation of their cancer diagnosis, beating their cancer and living a life that was not considered a possibility years ago. Our mission at Northwell Cancer Institute is to make this a reality for every single patient. Dr. Tsao is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Orchiectomy, and Nephrectomy. Dr. Tsao is board certified in American Board Of Internal Medicine/Medical Oncology.

Eran Ben is a Radiologist practicing medicine in Lake Success, New York. Dr. Ben is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Thyroid Nodule, Mikulicz Disease, Lymphofollicular Hyperplasia, and Tenosynovitis. Dr. Ben is board certified in American Board Of Radiology/Diagnostic Radiology.

As Senior Vice President of the Urology Service Line, Chair of theSmith Institute for Urology, and Chair of Urology at the Zucker Schoolof Medicine at Hofstra/Northwell, Samir Taneja, MD will establish hisclinical practice at Lenox Hill Hospital and Long Island Jewish MedicalCenter focused on the surgical management of prostate cancerand renal tumors. He is an expert in urologic oncology, renowned fortransforming the field of prostate cancer diagnosis and treatmentby improving methods of prostate imaging, cancer detection, anddisease localization. Having performed thousands of robotic, ablative,laparoscopic and open surgical procedures, his specific clinical focushas been in improving prostate cancer patient outcomes throughpioneering techniques for focal ablative therapy, refining surgicaltechniques for robotic prostatectomy and partial nephrectomy,devising accelerated recovery pathways for robotic prostatectomy/partial nephrectomy, and providing muti-modal surgical approachesfor patients with high risk and recurrent prostate cancer. As leader ofthe department, he will strive to ensure individualized care of urologicdisease through state-of-the-art surgical approaches and multi-disciplinary care.Prior to joining Northwell, Dr Taneja was a faculty member of NYUGrossman School of Medicine for 29-years as a tenured professorof urology, radiology, and biomedical engineering. Most recently heserved as Director of the Division of Urologic Oncology and ViceChair in the Department of Urology at NYU Langone Health, as well asGenitourinary Program Leader in the Perlmutter Cancer Center.Dr. Taneja has conducted extensive clinical research on the use ofimaging in prostate cancer and is considered a pioneer in the use ofMRI to diagnose and localize prostate cancer and the emerging field ofprostate cancer focal therapy. He has authored more than 250 articles,30 book chapters, and six textbooks and monographs on urologiccancer and surgery. He is the editor of Taneja's Complications ofUrologic Surgery: Prevention and Diagnosis, one of the most widely readtextbooks in American Urology. Dr. Taneja is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Prostatectomy, and Nephrectomy. Dr. Taneja is board certified in American Board Of Urology.

Dr. Simon J Hall MD is a board certified urologist with Fellowship training in Urologic Oncology. His clinical interests include the diagnosis and treatment of Prostate, Bladder and Kidney cancers. He is especially interested in Active Surveillance of men with prostate cancer and men and women with incidentally found small renal masses and the creation of continent urinary reconstructions for patients who need to undergo cystectomy for Bladder cancer. Furthermore, Dr. Hall has a keen interest in treating patients with recurrent prostate cancer following definitive therapy. He believes that objective & balanced communication with the patient and family is the key to decision making and individualized care. Over the years Dr. Hall has been named as Best Doctor, both nationally and regionally, by organizations such as Castle Connolly, SuperDoctors and New York Magazine. Dr. Hall s research has focused of new therapies for prostate and bladder cancer; he has participated in numerous clinical trials, some of which generated data resulting in FDA approval of Sipleucel-T (Provenge) and enzulutamide (Xtandi). He oversees a laboratory investigating novel approaches to negating the Androgen Receptor, an important key driver of castration resistant prostate cancer. Decision making and improved methods of clinical care for patients with bladder and prostate cancer are important aspects of his research interests in collaboration with Dr. Michael Diefenbach, a behavioral scientist in the Departments of Urology & Medicine at NS-LIJ. He has authored or co-authored nearly 70 peer reviewed articles in Journals such as Journal of Urology, Urology, British Journal of Urology, Clinical Cancer Research and Science. Dr. Hall received his MD from the College of Physicians & Surgeons of Columbia University. He then completed two years of Surgery training at the Mount Sinai Medical Center followed by a four year residency in Urology at Boston University School of Medicine. This was followed by a 2 year fellowship in Urologic Oncology in the Scott Department of Urology at Baylor College of Medicine. Prior to joining the Smith Institute for Urology, he served on the faculty of Icahn School of Medicine at Mount Sinai for 18 years, holding various positions including Kyung Hyun Kim MD Chair of Urology and the Director of the Deane Prostate Health & Research Center. Dr. Hall is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Prostate Cancer, Bladder Cancer, Nephrectomy, and Reconstructive Urology Surgery. Dr. Hall is board certified in American Board Of Urology.

Francis Arena is a Hematologist and an Oncologist practicing medicine in New Hyde Park, New York. Dr. Arena is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 42 other conditions, according to our data. His clinical expertise encompasses Angiosarcoma, Inflammatory Breast Cancer, Breast Cancer, and Paget Disease of the Breast. Dr. Arena is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine/Medical Oncology.

Anna Kurzyna is a Hematologist and an Oncologist practicing medicine in New Hyde Park, New York. Dr. Kurzyna is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. She is also highly rated in 33 other conditions, according to our data. Her clinical expertise encompasses Hemolytic Crisis, Childhood Iron Deficiency Anemia, Chronic Lymphocytic Leukemia (CLL), and Inflammatory Breast Cancer.

Michael J. Schwartz, MD, is Chief of Urology at Long Island Jewish Medical Center and Director of Urology Services for Northwell Health's Central Region. Dr. Schwartz specializes in minimally invasive procedures to treat prostate cancer. He has vast experience in robotic-assisted radical prostatectomy, evolving surgical techniques over time to minimize treatment-related side effects. For qualifying prostate cancer patients, Dr. Schwartz also offers focal ablation therapies, using sophisticated image guidance and focal tissue ablation to eradicate prostate cancer with few side effects. He has additional expertise in urologic oncology and surgery to treat kidney, bladder, adrenal and testicular cancers. Becoming a doctor always felt natural to me, Dr. Schwartz says. I was always interested in helping others, and urology is a wonderful blend of both medical and surgical care, allowing for the development of long-term relationships with my patients. Dr. Schwartz earned his medical degree from Warren Alpert Medical School of Brown University and pursued his residency training in urology at New York-Presbyterian Hospital, Cornell. He received his fellowship training in advanced laparoscopic and endoscopic surgery at North Shore University Hospital and Long Island Jewish Medical Center. Dr. Schwartz values a team-based approach to care, working with radiologists, pathologists and medical oncologists to create individualized, evidence-based treatment plans. He also carefully listens to patients to meet their unique goals and preferences. In addition to treating prostate cancer, Dr. Schwartz is a pioneer in prostate cancer diagnosis. He was an early adopter of transperineal biopsy-which eliminates the infection risk associated with the prior transrectal method-and helped the Smith Institute of Urology transition to using that approach for all patients requiring prostate biopsy across Northwell Health. His research focuses on both diagnostics and treatment of prostate cancer, and he is involved with several clinical trials for focal therapy. He is a member of the American Urological Association and Society of Urologic Oncology. He is Associate Professor of Urology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. For Dr. Schwartz, one of the best parts of his job is getting to know his patients. I have the privilege of seeing their humanity, learning about their lives and discovering what's important to them, he says. Their experiences inspire me every day. Dr. Schwartz is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Enlarged Prostate (BPH), Reconstructive Urology Surgery, and Nephrectomy. Dr. Schwartz is board certified in American Board Of Urology.

Janet Hoffman is a Radiologist practicing medicine in Lake Success, New York. Dr. Hoffman is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Angiomyoma, Uterine Fibroids, Tenosynovitis, and Gallbladder Disease. Dr. Hoffman is board certified in American Board Of Radiology/Diagnostic Radiology.

David Chan is a Urologist practicing medicine in Lake Success, New York. Dr. Chan is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Obstructive Uropathy, Boils, Ureteroscopy, and Prostatectomy. Dr. Chan is board certified in American Board Of Urology.

David M. Hoenig, MD, is a specialist in kidney stone treatment and minimally invasive surgery, including laparoscopic surgery. His specific clinical interests include all phases of kidney stone disease, from surgical treatment, to medical management, and to prevention. Dr. Hoenig completed medical school at the University of Rochester (Rochester, NY), and residency in Urology at Brown University (Providence, RI). He went on to one of the premier Laparoscopy and Endourology Fellowships in the country, under Dr. Ralph V. Clayman, one of the pioneers of minimally invasive urologic surgery, at Washington University (St. Louis, MO).After Fellowship training, Dr. Hoenig became a Clinical Instructor at the Medical College of Pennsylvania/Hahnemann under the auspices of Allegheny University, and was then recruited to Montefiore Medical Center/Albert Einstein College of Medicine to become the Director of Laparoscopy and Endourology and promoted to Assistant Professor. While at Montefiore, Dr. Hoenig assumed many administrative roles, as co-founder and co-Director of the Robotic, Laparoscopy, and Endourology Fellowship, Residency Program Director, and Practice Manager. After more than 14 years at Montefiore/Albert Einstein, he was recruited to North Shore- Long Island Jewish Hospital in 2013 with a promotion to Professor, and a shift of administrative roles to Chief of Urology Service at LIJ Hospital Campus. Dr. Hoenig's research interests are in all phases of minimally invasive urologic surgery, with particular attention to kidney stone disease, and both ablative and reconstructive minimally invasive renal surgery. His most recent publications explore the association of obesity with urological diseases, with new associations discovered between types of obesity and certain kidney stones. This research focus is a priority, given the national trend of increasing obesity, and will lead to exciting basic science exploration of these conditions.As a clinician, Dr. Hoenig's priority is treating patients with respect and empathy. He believes strongly in educating patients about their conditions, so as to equip them with the necessary information to make them a partner in their health care. Dr. Hoenig is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Kidney Stones, Medullary Sponge Kidney, Perirenal Abscess, Ureteroscopy, and Endoscopy. Dr. Hoenig is board certified in American Board Of Urology.

Nagashree Seetharamu, MD, MBBS, is an Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Internal Medicine, Hematology, Medical Oncology and Hospice/Palliative medicine, she specializes in cancers of the head and neck and thoracic malignancies (lung cancer, mesothelioma, thymic tumors). She maintains an active clinical practice at the Monter Cancer Center where she focuses on providing compassionate, personalized, evidence-based multidisciplinary care. Dr. Seetharamu has established her reputation at the national level through her active involvement, and leadership within influential oncology organizations that steer the direction of clinical cancer care and research across the United States, and globally. She is a full member of both the Cancer Prevention Committee and Respiratory Committee of Alliance for Clinical Trials in Oncology. This is a national, NCI-sponsored, cooperative group that develops, fund and conducts clinical trials at many academic and community oncology centers across the country. In her position on these committees, she collaborates with clinical research experts across the country to establish standards-of-care, oversees the conduct of existing clinical trials, develops innovative and impactful hypotheses, and formulate future clinical trials. Dr. Seetharamu is the institutional principal investigator on over 10 clinical trials, has co-authored over 50 publications and book chapters and is a sought after speaker at various regional, national and international events related to Head and Neck and Thoracic cancer. Dr. Seetharamu is also Associate Program Director of the Medical Oncology and Hematology Fellowship Program for the Northwell Health Cancer Institute. In this role, she provides hands-on involvement in the recruitment, education and mentorship of future generations of physicians. Dr. Seetharamu trained in internal medicine at Long Island Jewish Medical Center and in hematology/oncology at New York University Medical Center. Dr. Seetharamu is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. She is also highly rated in 28 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer. Dr. Seetharamu is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hospice & Palliative Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Dr. Crina Vintila is an attending physician double board-certified in medical oncology and hematology, who has served the Long Island community for more than 20 years at the Don Monti Cancer Center at Glen Cove Hospital, Huntington Cancer Institute, and most recently, at the Monter Cancer Center.Being part of the Northwell Health System for more than 2 decades, her practice has focused on delivering individualized, evidence-based patient care, in a multidisciplinary setting, with active participation in research trials. She takes special interest in breast, gastrointestinal, and hematologic malignancies.Dr.Vintila earned her medical degree at the Institute of Medicine and Pharmacy, Bucharest, Romania. She completed internal medicine training at the Weil Cornell / NY Hospital -Booth Memorial Medical Center, and her hematology and medical oncology fellowship at Winthrop University Hospital.Dr.Vintila is fluent in Romanian, Spanish and French. Dr. Vintila is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Squamous Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and ALK-Positive Non-Small Cell Lung Cancer. Dr. Vintila is board certified in American Board Of Internal Medicine/Medical Oncology.

Manish Vira is a Urologist practicing medicine in New Hyde Park, New York. Dr. Vira is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Bladder Cancer, Prostate Cancer, Nephrectomy, and Reconstructive Urology Surgery.

Michael J. Drabkin, MD is the Chief of Interventional Radiology at NY Imaging / New York Cancer & Blood Specialists (NYCBS), serving Long Island and the greater New York City area. He is board-certified in both Diagnostic Radiology and Interventional Radiology.His practice focuses on minimally invasive, same-day treatments for enlarged prostate (BPH), uterine fibroids, varicoceles, and cancer. Dr. Drabkin performs more than 650 Prostate Artery Embolizations (PAE) per year, placing him among the highest-volume PAE physicians in the United States. He has performed over 20,000 image-guided procedures during his career.He completed his fellowship in Vascular and Interventional Radiology at Memorial Sloan Kettering Cancer Center and Weill Cornell Medical Center, where he served as Chief Fellow. He earned his undergraduate degree at Columbia University and his medical degree from SUNY Upstate Medical University.Dr. Drabkin is a Castle Connolly Top Doctor, and an active member of the Society of Interventional Radiology and the American Urological Association. He is well published in professional journals, and has been an invited speaker at national and international conferences. Dr. Drabkin is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Ascites, Familial Colorectal Cancer, Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, and Liver Embolization. Dr. Drabkin is board certified in Interventional Radiology and Diagnostic Radiology. Dr. Drabkin is currently accepting new patients.

Corinne Liu is a Radiologist practicing medicine in Mineola, New York. Dr. Liu is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer, Metastatic Pleural Tumor, Lung Nodules, and Lymphofollicular Hyperplasia.

Anthony Corcoran is an Oncologist practicing medicine in Garden City, New York. Dr. Corcoran is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Prostate Cancer, Renal Cell Carcinoma (RCC), Nephrectomy, and Vasectomy.

Summa cum laude graduate of the University of Missouri in Columbia, MO. Honors graduate of the Saint Louis University School of Medicine in St. Louis, MO. Chief Resident and graduate of the Hofstra - Northwell Radiology Residency in Manhasset, NY. Graduate of the University of North Carolina Vascular and Interventional Radiology Fellowship in Chapel Hill, NC. Currently an Assistant Professor of Radiology at the Zucker School of Medicine at Hofstra/Northwell, and Attending Interventional Radiologist at North Shore University Hospital and Long Island Jewish - Valley Stream. Special areas of expertise include vascular malformations, lymphatic malformations, trauma, and bronchial artery interventions. Dr. Al is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Ascites, Pleurisy, Pleural Effusion, Gastrostomy, and Liver Embolization. Dr. Al is board certified in American Board Of Radiology.